Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized, Vehicle-Controlled Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 Gel in Subjects With Plaque Psoriasis

NCT03630939 is registered in ClinicalTrials.gov with Escalier Biosciences B.V. as lead sponsor.

NCT NCT03630939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03630939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized, Vehicle-Controlled Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 Gel in Subjects With Plaque Psoriasis
Lead sponsor
Escalier Biosciences B.V.
Phase
Phase 1/2
Overall status
Completed
Start date
August 9, 2018
Completion date
June 12, 2019
Enrollment
104 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic plaque